GénistéineGenistein
A soya isoflavone, a competitive inhibitor of FAAH; its effect on anandamide uptake was reinterpreted in 2007.
C₁₅H₁₀O₅
CAS 446-72-0
- Family
- ECS pharmacological toolEnzyme inhibitor
- Molar mass
- 270.24 g/mol
Updated on
In plain terms
Genistein is a plant isoflavone found notably in soy. It was used in the laboratory to block a cellular mechanism, until a 2007 study showed that its effect on anandamide actually goes through inhibition of the enzyme that destroys that molecule. These results come from cells and homogenates; no study in humans on this effect was found.
Receptors and activity
Target network
- Blocks or inhibits
The lower the cited value, the closer the target sits to Génistéine: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of Génistéine.
FAAHFAAH found in 7 regions of the body
- CortexpresentCortical pyramidal neurons1
- Basal gangliapresentStriatal neurons1
- HypothalamuspresentPresent in hypothalamic nuclei1
- CerebellumpresentPurkinje cells and cerebellar layers1
- BrainstempresentInferior olivary nuclei1
- Adipose tissuepresentExpressed in mature adipocytes2
- BonepresentPresent on osteoclasts3
Map sources
- Romero J et al. Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. Brain Res Mol Brain Res, 2002 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Rossi F et al. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone, 2009 (new tab)
Cited values
- FAAHInhibitorIC50 = 3.6 µM · rat24 out of 100
Thors et al., Br J Pharmacol 2007 (full text PMC2190009) (new tab) · hydrolysis of [3H-ethanolamine]anandamide (2 µM), RBL2H3 cell homogenates (pI50 5.44 ± 0.05); 5.4 µM in intact cells; competitive inhibition
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of Génistéine, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Genistein is a plant isoflavone, a tyrosine kinase inhibitor used in the laboratory to block caveolae-dependent endocytosis. This use brought it into the endocannabinoid literature: it reduced anandamide uptake by RBL2H3 cells, which was attributed to endocytosis. Thors, Eriksson and Fowler recalled in 2007 that it is also a competitive inhibitor of FAAH, the enzyme that hydrolyses anandamide, then showed that daidzein, which does not act on tyrosine kinases, reproduces its effect on uptake, and that this effect appears only in URB597-sensitive cell lines. Their conclusion is that FAAH blockade is the primary determinant of genistein's effect on cellular anandamide uptake. Genistein's IC50 on anandamide hydrolysis is 3.6 µM (RBL2H3 homogenates) and 5.4 µM (intact cells). In 2008, Thors, Belghiti and Fowler extended FAAH inhibition to flavonoids: kaempferol, the most potent of the common flavonoids, inhibits FAAH competitively with a Ki of 5 µM. These results concern cells and homogenates; genistein is also a phytoestrogen (Kuiper et al. 1998), which limits its use as a selective tool of the endocannabinoid axis.
Key sources.
- Thors L, Eriksson J, Fowler CJ. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol, 2007 (new tab)PMID 17676056
- Thors L, Belghiti M, Fowler CJ. Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. Br J Pharmacol, 2008 (new tab)PMID 18552875
- Kuiper GG et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 1998 (new tab)PMID 9751507
- PubChem, genistein, CID 5280961 (identifiers and properties) (new tab)
History
- Source
- A plant isoflavone, not produced by cannabis: the fiche's master database lists 273 producing taxa, including Trifolium pratense and Lupinus albus. It is also used as a research reagent (Thors et al. 2007).
Origin
Research tool
No relation to cannabinoid biosynthesis: genistein is a secondary metabolite of plants (legumes in particular), not of cannabis. The detail of its formation pathway was not verified in this pass.
Legal framework
- European Union
The substance is not listed in the Annex to Council Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which lists the new psychoactive substances controlled at European Union level; control is a matter for national law. It is not listed in the schedules of the 1971 Convention on Psychotropic Substances (INCB Green List, 36th edition, 2025, text reviewed). No marketing authorisation as a medicine was found.
- France
Not classified: genistein is not on the ANSM consolidated list of narcotics (updated 16/02/2026) and this isoflavone falls within none of the generic families of that list.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Enzyme inhibitor
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Thors L, Eriksson J, Fowler CJ. Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol, 2007 (new tab)PMID 17676056
- Thors L, Belghiti M, Fowler CJ. Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. Br J Pharmacol, 2008 (new tab)PMID 18552875
- Kuiper GG et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 1998 (new tab)PMID 9751507
- PubChem, genistein, CID 5280961 (identifiers and properties) (new tab)
Identifiers
Names
- Common name
- Genistein
- IUPAC name
- 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one
- Other names
- 4',5,7-trihydroxyisoflavone
Identifiers
- Formula
- C₁₅H₁₀O₅
- CAS
- 446-72-0
- PubChem CID
- 5280961(new tab)
- InChIKey
- TZBJGXHYKVUXJN-UHFFFAOYSA-N
- SMILES
- C1=
CC(= CC= C1C2= COC3= CC(= CC(= C3C2= O) O) O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.